<p>Chemomab Therapeutics Ltd. will participate in Oppenheimer’s Movers in Rare Disease Summit on December 11, 2025, at the Sofitel Hotel in New York City. Co-founder and CEO Adi Mor, PhD, is scheduled to present a corporate overview from 2:15 to 2:45 pm EST and will be available for one-on-one meetings with registered attendees. The summit will feature panels, presentations, and investor meetings focused on companies working in the rare disease space. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9591036-en) on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

CMMB

<p>Chemomab Therapeutics Ltd. will participate in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025, in New York City. CEO Adi Mor will present a corporate overview and engage in one-on-one meetings. The summit focuses on rare disease companies. This news was generated by Public Technologies using AI and is for informational purposes only.</p>

Chemomab Therapeutics CEO to Present at Oppenheimer Movers in Rare Disease Summit